Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Heng-Gu-Gu-Shang-Yu-He-Ji is a Traditional Chinese Medicine (TCM) oral liquid formulation primarily indicated for the treatment of bone fractures, osteoarthritis, and osteoporosis. It is composed of several herbal and mineral ingredients, including *Panax notoginseng*, *Carthamus tinctorius*, and *Drynaria fortunei*. The drug works by promoting osteoblast differentiation and proliferation while inhibiting osteoclast activity, thereby accelerating bone healing and increasing bone mineral density. Additionally, it improves local blood circulation and exhibits anti-inflammatory and analgesic properties. It is widely used in China for orthopedic conditions to shorten fracture healing time and alleviate pain associated with degenerative joint diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Heng-Gu-Gu-Shang-Yu-He-Ji.